Authors
Loading...
Randomized trial analyzes FDA novel drug approvals, indicating shifts in therapeutic technologies and pathways.
Dr. Nehanand*, Dr. Pankaj Gupta, Dr. Jasleen Kaur, Dr. Jyoti Maria, Dr. Naufal, Dr. Sahil Kumar (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: